9 December 2021

Biologics Scleroderma

Promising findings for PsA treatments

9 December 2021

Biologics Clinical Software

Antibody trial finds reduction in Sjögren’s syndrome disease activity

9 December 2021

Biologics Comment Conditions

Read the November magazine online!

25 November 2021

Biologics Conditions

What else is your hypertensive patient taking?

25 November 2021

Biologics Comment COVID-19

Black Friday decision making, Covid and rituximab: is anyone buying?

18 November 2021

Biologics COVID-19

Cardiac toxicity risks with HCQ and CQ

18 November 2021

Biologics Conditions

Slow-release opioid therapy helps GPs treat illicit drug use

11 November 2021

Biologics Conditions Mental Health

Barbiturate scripts halve, but death rates spike

9 November 2021

Ankylosing Spondylitis Biologics Gout Pharmacy Guild of Australia

What’s on the way for GCA?

4 November 2021

Biologics Pregnancy Scleroderma Women

PsA patients and pregnancy risks

28 October 2021

Biologics Gout Research

Spare a thought for the sperm

21 October 2021

Biologics Spondyloarthritis

Another drug shortage – now it’s abatacept

21 October 2021

Ankylosing Spondylitis Biologics Biosimilars Conditions O&G

How to help patients understand their biosimilar options

18 October 2021

Biologics Reactive Arthritis

Rituximab in line for open PBS listing without authority

14 October 2021

Biologics Comment Conditions

Read the September magazine online!

11 October 2021

Biologics PBAC

Avacopan FDA-approved for ANCA-associated vasculitis